Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $909.90 | 1 | 68.1% |
| Food and Beverage | $243.69 | 4 | 18.2% |
| Education | $183.13 | 1 | 13.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE HEALTHCARE | $909.90 | 1 | $0 (2017) |
| Zimmer Biomet Holdings, Inc. | $183.13 | 1 | $0 (2022) |
| CONMED Corporation | $171.27 | 1 | $0 (2018) |
| Almatica Pharma LLC | $55.68 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $16.74 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $183.13 | 1 | Zimmer Biomet Holdings, Inc. ($183.13) |
| 2021 | $55.68 | 2 | Almatica Pharma LLC ($55.68) |
| 2018 | $171.27 | 1 | CONMED Corporation ($171.27) |
| 2017 | $926.64 | 2 | GE HEALTHCARE ($909.90) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2022 | Zimmer Biomet Holdings, Inc. | Avenir (Device) | Education | In-kind items and services | $183.13 | General |
| Category: Hips | ||||||
| 02/03/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: ANALGESIC | ||||||
| 01/19/2021 | Almatica Pharma LLC | NAPRELAN (Drug), GRALISE | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: ANALGESIC | ||||||
| 08/22/2018 | CONMED Corporation | CONMED Biliary (Device) | Food and Beverage | In-kind items and services | $171.27 | General |
| Category: General Surgery | ||||||
| 12/13/2017 | GE HEALTHCARE | CARDIOVASCULAR DISEASE (Device) | Travel and Lodging | Cash or cash equivalent | $909.90 | General |
| Category: GLOBAL MARKETING | ||||||
| 12/12/2017 | GlaxoSmithKline, LLC. | SHINGRIX (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,340 | 2,369 | $873,438 | $174,239 |
| 2022 | 24 | 1,350 | 2,385 | $646,861 | $159,187 |
| 2021 | 22 | 1,705 | 2,647 | $635,520 | $158,259 |
| 2020 | 19 | 1,390 | 2,349 | $594,852 | $133,468 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 401 | 1,161 | $592,630 | $104,017 | 17.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 62 | 62 | $82,088 | $17,476 | 21.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 100 | 100 | $41,100 | $13,842 | 33.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 147 | 148 | $45,140 | $11,198 | 24.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 21 | $16,317 | $4,842 | 29.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 155 | 156 | $4,680 | $4,692 | 100.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 23 | 24 | $13,248 | $3,875 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 51 | $18,594 | $3,197 | 17.2% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 17 | 17 | $3,315 | $2,184 | 65.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 62 | 62 | $5,518 | $2,042 | 37.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $15,090 | $1,801 | 11.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 50 | 71 | $6,661 | $1,022 | 15.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 82 | $7,016 | $968.50 | 13.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 16 | $4,048 | $853.85 | 21.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 17 | 17 | $1,360 | $745.64 | 54.8% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 13 | 13 | $1,287 | $570.96 | 44.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 29 | $2,262 | $276.08 | 12.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 23 | $3,335 | $248.20 | 7.4% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 13 | 16 | $1,225 | $200.81 | 16.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 25 | 111 | $4,548 | $94.02 | 2.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 43 | $602.00 | $51.34 | 8.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 24 | 102 | $3,374 | $42.00 | 1.2% |
| 91312 | Sarscov2 vac bvl 30mcg/0.3ml | Office | 2023 | 14 | 14 | $0.14 | $0.14 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 383 | 1,165 | $431,050 | $102,388 | 23.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 68 | 68 | $27,948 | $9,466 | 33.9% |
About Dr. David Lee, M.D
Dr. David Lee, M.D is a Internal Medicine healthcare provider based in Elk Grove, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003832346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lee, M.D has received a total of $1,337 in payments from pharmaceutical and medical device companies, with $183.13 received in 2022. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($909.90).
As a Medicare-enrolled provider, Lee has provided services to 5,785 Medicare beneficiaries, totaling 9,750 services with total Medicare billing of $625,153. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Elk Grove, CA
- Active Since 07/13/2006
- Last Updated 12/02/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003832346
Products in Payments
- CARDIOVASCULAR DISEASE (Device) $909.90
- Avenir (Device) $183.13
- CONMED Biliary (Device) $171.27
- NAPRELAN (Drug) $55.68
- SHINGRIX (Drug) $16.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elk Grove
Mahmoud Khattab, Md, MD
Internal Medicine — Payments: $88,986
Jude Waterbury, Md, MD
Internal Medicine — Payments: $5,431
Dr. Chou Wu, Md, MD
Internal Medicine — Payments: $1,098
Muhammad Zubair, M.d, M.D
Internal Medicine — Payments: $281.20
Shahin Shahbazi, Md, MD
Internal Medicine — Payments: $256.63
Dr. Yogesh Nandan, M.d, M.D
Internal Medicine — Payments: $206.38